Search

Ian D. Dang

Examiner (ID: 7410)

Most Active Art Unit
1647
Art Unit(s)
1647
Total Applications
358
Issued Applications
151
Pending Applications
21
Abandoned Applications
186

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6449674 [patent_doc_number] => 20100145007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'CHIMERIC PEPTIDE ANTAGONIST FOR GPCR135 OR GPCR142' [patent_app_type] => utility [patent_app_number] => 12/449137 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6792 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145007.pdf [firstpage_image] =>[orig_patent_app_number] => 12449137 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/449137
Chimeric peptide antagonist for GPCR135 or GPCR142 Jan 22, 2008 Issued
Array ( [id] => 6231399 [patent_doc_number] => 20100184661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/522661 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9966 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184661.pdf [firstpage_image] =>[orig_patent_app_number] => 12522661 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/522661
CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF Jan 9, 2008 Abandoned
Array ( [id] => 7680709 [patent_doc_number] => 20100105877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT' [patent_app_type] => utility [patent_app_number] => 12/523050 [patent_app_country] => US [patent_app_date] => 2008-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9955 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105877.pdf [firstpage_image] =>[orig_patent_app_number] => 12523050 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/523050
Insulinotropic complex using an immunoglobulin fragment Jan 3, 2008 Issued
Array ( [id] => 5435535 [patent_doc_number] => 20090170122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Human intestinal NPT2B' [patent_app_type] => utility [patent_app_number] => 12/002624 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12119 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170122.pdf [firstpage_image] =>[orig_patent_app_number] => 12002624 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/002624
Method for screening human intestinal Npt2B modulatory agents Dec 17, 2007 Issued
Array ( [id] => 4727968 [patent_doc_number] => 20080207512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Methods for Treating Obesity and Obesity Related and Disorders' [patent_app_type] => utility [patent_app_number] => 11/940317 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 38446 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 68 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207512.pdf [firstpage_image] =>[orig_patent_app_number] => 11940317 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/940317
Methods of treating obesity with two different anti-obesity agents Nov 13, 2007 Issued
Array ( [id] => 4845487 [patent_doc_number] => 20080181895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'SP16 protein' [patent_app_type] => utility [patent_app_number] => 11/979577 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21637 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181895.pdf [firstpage_image] =>[orig_patent_app_number] => 11979577 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/979577
SP16 protein Nov 5, 2007 Abandoned
Array ( [id] => 5485970 [patent_doc_number] => 20090275735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'MONOCLONAL ANTIBODIES TO HUMAN CTLA-8 (IL-17A)' [patent_app_type] => utility [patent_app_number] => 11/930368 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17948 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275735.pdf [firstpage_image] =>[orig_patent_app_number] => 11930368 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/930368
Monoclonal antibodies to human CTLA-8 (IL-17A) Oct 30, 2007 Issued
Array ( [id] => 4965752 [patent_doc_number] => 20080108572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Methods and compositions for control of fetal growth via modulation of relaxin' [patent_app_type] => utility [patent_app_number] => 11/981338 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32430 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108572.pdf [firstpage_image] =>[orig_patent_app_number] => 11981338 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/981338
Methods and compositions for control of fetal growth via modulation of relaxin Oct 30, 2007 Abandoned
Array ( [id] => 4903997 [patent_doc_number] => 20080113410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Method for Rational Pegylation of Proteins' [patent_app_type] => utility [patent_app_number] => 11/930051 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15429 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113410.pdf [firstpage_image] =>[orig_patent_app_number] => 11930051 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/930051
Method for Rational Pegylation of Proteins Oct 29, 2007 Abandoned
Array ( [id] => 33392 [patent_doc_number] => 07786077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Insulins combinations' [patent_app_type] => utility [patent_app_number] => 11/927172 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14655 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/786/07786077.pdf [firstpage_image] =>[orig_patent_app_number] => 11927172 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/927172
Insulins combinations Oct 28, 2007 Issued
Array ( [id] => 5580930 [patent_doc_number] => 20090176276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide' [patent_app_type] => utility [patent_app_number] => 11/927628 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 12485 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176276.pdf [firstpage_image] =>[orig_patent_app_number] => 11927628 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/927628
Methods of treating using hormone-albumin fusion proteins Oct 28, 2007 Issued
Array ( [id] => 5585004 [patent_doc_number] => 20090104206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Bone microenvironment modulated migraine treatments' [patent_app_type] => utility [patent_app_number] => 11/975465 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14881 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104206.pdf [firstpage_image] =>[orig_patent_app_number] => 11975465 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/975465
Bone microenvironment modulated migraine treatments Oct 18, 2007 Abandoned
Array ( [id] => 6600845 [patent_doc_number] => 20100098689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => '4-1 bb ligand in inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 12/311170 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22565 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098689.pdf [firstpage_image] =>[orig_patent_app_number] => 12311170 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/311170
4-1 bb ligand in inflammatory diseases Oct 15, 2007 Abandoned
Array ( [id] => 6316953 [patent_doc_number] => 20100112566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/442372 [patent_app_country] => US [patent_app_date] => 2007-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16097 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112566.pdf [firstpage_image] =>[orig_patent_app_number] => 12442372 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/442372
VIPR1S as Modifiers of the E2F/RB Pathway and Methods of Use Sep 23, 2007 Abandoned
Array ( [id] => 6430599 [patent_doc_number] => 20100143330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE' [patent_app_type] => utility [patent_app_number] => 12/445928 [patent_app_country] => US [patent_app_date] => 2007-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15539 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143330.pdf [firstpage_image] =>[orig_patent_app_number] => 12445928 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/445928
METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE Sep 23, 2007 Abandoned
Array ( [id] => 5385776 [patent_doc_number] => 20090227021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'PURIFIED MAMMALIAN CTLA-8 ANTIGENS AND RELATED REAGENTS' [patent_app_type] => utility [patent_app_number] => 11/848672 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17888 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227021.pdf [firstpage_image] =>[orig_patent_app_number] => 11848672 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/848672
PURIFIED MAMMALIAN CTLA-8 ANTIGENS AND RELATED REAGENTS Aug 30, 2007 Abandoned
Array ( [id] => 6306522 [patent_doc_number] => 20100069321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Biological Materials and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/439423 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13467 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069321.pdf [firstpage_image] =>[orig_patent_app_number] => 12439423 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/439423
Biological Materials and Uses Thereof Aug 30, 2007 Abandoned
Array ( [id] => 4845493 [patent_doc_number] => 20080181901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Protein modulator of the plasma membrane Na,K-ATPase' [patent_app_type] => utility [patent_app_number] => 11/892666 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11001 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181901.pdf [firstpage_image] =>[orig_patent_app_number] => 11892666 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/892666
Nucleic acids encoding proteins for modulating Na,K-ATPase Aug 23, 2007 Issued
61/190035 Amino acid substituted molecules Aug 19, 2007 Pending
Array ( [id] => 4441443 [patent_doc_number] => 07927852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates' [patent_app_type] => utility [patent_app_number] => 11/882750 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7168 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/927/07927852.pdf [firstpage_image] =>[orig_patent_app_number] => 11882750 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/882750
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates Aug 2, 2007 Issued
Menu